NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbf -SMMHC via activation of MEK/ERK axis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbf -SMMHC via activation of MEK/ERK axis
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 3, Pages 426-436
Publisher
American Society of Hematology
Online
2014-06-04
DOI
10.1182/blood-2013-12-541730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects
- (2013) Min Yang et al. ANNALS OF HEMATOLOGY
- NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions
- (2013) J. Wang et al. BLOOD
- Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation
- (2013) J. Xu et al. Cancer Discovery
- Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)
- (2012) P. Paschka et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
- (2012) Tiffany Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene
- (2011) F.-S. Chou et al. BLOOD
- GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway
- (2011) J. J. Wallin et al. MOLECULAR CANCER THERAPEUTICS
- Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells
- (2011) Xiongwei Cai et al. PLoS One
- A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
- (2011) N. Lyubynska et al. Science Translational Medicine
- Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
- (2010) Q. Li et al. BLOOD
- Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia
- (2010) J. Wang et al. BLOOD
- AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
- (2010) C Haferlach et al. LEUKEMIA
- Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
- (2009) Jennifer O. Lauchle et al. NATURE
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Targeting Ras in Myeloid Leukemias
- (2008) B. S. Braun et al. CLINICAL CANCER RESEARCH
- M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience
- (2008) A. Pulsoni et al. HAEMATOLOGICA
- Cooperating gene mutations in acute myeloid leukemia: a review of the literature
- (2008) A Renneville et al. LEUKEMIA
- Multisite Phosphorylation Regulates Bim Stability and Apoptotic Activity
- (2008) Anette Hübner et al. MOLECULAR CELL
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
- Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
- (2008) A M S Müller et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now